Impaired fibrinolysis in patients with thrombotic or haemostatic defects
- 1 September 1989
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 55 (5) , 559-567
- https://doi.org/10.1016/0049-3848(89)90388-5
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Increased concentration of the fast‐acting plasminogen activator inhibitor in plasma associated with familial venous thrombosisBritish Journal of Haematology, 1987
- The Role of the Fibrinolytic System in Thrombotic DiseaseActa Medica Scandinavica, 1987
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.BMJ, 1985
- The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after traumaScandinavian Journal of Clinical and Laboratory Investigation, 1985
- An assessment of the fibrinolytic system in hemophilia AAmerican Journal of Hematology, 1982
- A NEW METHOD FOR THE QUANTITATIVE DETECTION OF PLATELET AGGREGATES IN PATIENTS WITH ARTERIAL INSUFFICIENCYThe Lancet, 1974
- Plasminogen: Purification from Human Plasma by Affinity ChromatographyScience, 1970
- A STANDARDIZED TECHNIQUE FOR THE BLOOD SEDIMENTATION TESTThe Lancet Healthy Longevity, 1935